Work

Pre-treatment partial-volume-corrected TLG is the best predictor of overall survival in patients with relapsing/refractory non-hodgkin lymphoma following radioimmunotherapy.

Year: 2018

Type: article

Abstract: = 0.02). Our results showed that pre-treatment pvcTLG was the best predictor of OS in patients with relapsing/refractory NHL following RIT.

Source: Europe PMC (PubMed Central)

Authors: Raheleh Taghvaei, Mahdi Zirakchian Zadeh, Reza Sirous, Sara Pourhassan Shamchi, William Y Raynor, Siavash Mehdizadeh Seraj, Mateen Moghbel, Shiyu Wang, Thomas J Werner, Hongming Zhuang, Abass Alavi

Institutions: Hospital of the University of Pennsylvania, Children's Hospital of Philadelphia, University of Maryland Medical Center, Drexel University, Stanford Medicine

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2997171527

FWCI: 0.951

Cites: 31

Cited by: 11

Related to: 10